WallStreetZenWallStreetZen

AnalystsColin Bristow
Colin Bristow's Stock Forecasts

Analyst Ranking
Bottom 2%
#4077 out of 4126 analysts
Average Return
-31.32%
Win Rate
19%3 out of 16
Risk vs Reward
Poor
Good

Colin Bristow's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Rocket Pharmaceuticals IncRCKT
+47.48%$13.48$19.88
2022-09-27 -
2022-12-02
Strong Buy
Biogen IncBIIB
+13.97%$262.26$298.90
2022-10-06 -
2022-12-02
Strong Buy
Prokidney CorpPROK
+3.41%$9.97$10.31
2022-10-18 -
2022-12-02
Strong Buy

Colin Bristow's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Prokidney CorpPROK
1Strong Buy$18.00+74.59%Initiates Coverage On
2 months ago
Biogen IncBIIB
4Strong Buy$309.00+3.38%Maintains
2 months ago
Rocket Pharmaceuticals IncRCKT
1Strong Buy$62.00+211.87%Maintains
2 months ago
Immunovant IncIMVT
2Hold$5.00-65.94%Downgrades
2 months ago
Abbvie IncABBV
2Hold$146.00-10.79%Maintains
4 months ago
Bristol Myers Squibb CoBMY
1Hold$75.00-7.56%Maintains
4 months ago
Merck & Co IncMRK
2Hold$98.00-10.94%Maintains
5 months ago
C4 Therapeutics IncCCCC
1Strong Buy$26.00+203.74%Maintains
8 months ago
Bioxcel Therapeutics IncBTAI
2Strong Buy$25.00+37.89%Maintains
10 months ago
Pfizer IncPFE
1Strong Buy$60.00+17.86%Upgrades
a year ago
Candel Therapeutics IncCADL
1Strong Buy$9.00N/AInitiates Coverage On
a year ago
Acumen Pharmaceuticals IncABOS
1Strong Buy$27.00N/AInitiates Coverage On
a year ago
Alx Oncology Holdings IncALXO
1Strong Buy$96.00N/AInitiates Coverage On
2 years ago
Omeros CorpOMER
1Strong Buy$25.00N/AInitiates Coverage On
2 years ago
Molecular Templates IncMTEM
1Hold$13.00N/AInitiates Coverage On
2 years ago
Sarepta Therapeutics IncSRPT
2HoldN/AN/ADowngrades
2 years ago
Vertex Pharmaceuticals IncVRTX
1Strong Buy$287.00N/AInitiates Coverage On
2 years ago
Ptc Therapeutics IncPTCT
1Hold$55.00N/AInitiates Coverage On
2 years ago
Gilead Sciences IncGILD
1Hold$61.00N/AInitiates Coverage On
2 years ago
Amgen IncAMGN
1Hold$232.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.